Sodium Channel Gene Variation in the Treatment of Epilepsy
Principal Investigator: Katherine D Holland
Abstract: PROJECT SUMMARY/ABSTRACT Initial antiepileptic treatment fails in over 40% of people with epilepsy, resulting in significant personal, financial, and societal hardships. The objective of this proposal is to determine the influence of genetic alterations in sodium channel genes on response to carbamazepine (CBZ), one of the main first line treatments for epilepsy. It is hypothesized that single nucleotide polymorphisms (SNPs) in sodium channel genes which change the amino acid composition of the resultant channel (nonsynonymous SNPs) alter the channel's responsiveness to CBZ resulting in treatment failure in some people with epilepsy. To achieve the objective of this application the specific aims are to (1) Identify single nucleotide polymorphisms in sodium channel [unreadable]- subunit genes expressed in the central nervous system that occur more frequently in patients with epilepsy unresponsive to initial CBZ therapy than in patients with CBZ-responsive epilepsy;and (2) Determine how SNPs in sodium channel [unreadable]-subunit genes affect electrophysiological and pharmacological properties of sodium channels in vitro. To accomplish these aims, first nonsynonymous variations in sodium channel genes occurring people with epilepsy that is unresponsive to CBZ will be identified and the frequency of these SNPs will be compared between patients with epilepsy that is unresponsive to CBZ, patients with epilepsy that responds to CBZ, and gender and ethnicity matched controls. Subsequently, the functional consequences of these sodium channel SNPs will be studied in vitro with whole cell patch clamp techniques using heterologously expressed recombinant human sodium channels. The motivation of the proposed research is that once the influence of sodium channel SNPs on CBZ responsiveness is understood, more efficacious therapies for epilepsy can be developed both by providing a way to pre-select treatment tailored to individual patients and by promoting the development of more effective genetic based therapies. This work is innovative because it links phenotype (CBZ resistant epilepsy), genotype (sodium channel SNPs) and functionality (alteration in channel responsiveness to AEDs);it is also innovative because the design of the pharmacogenetic association study involves a consecutive cohort of newly diagnosed patients taking a single AED whose response to treatment will be rigorously assessed. It is expected that sodium channel gene polymorphisms will be identified that are clinically associated with CBZ failure and alter sodium channel CBZ responsiveness;this will lead to a future prospective study to test whether CBZ responsiveness can be predict pre-treatment in patients with newly diagnosed epilepsy. From the functionality studies, in vitro methods for screening new AEDs can be developed. These results will have a positive impact by advancing understanding of how failure of first-line CBZ treatment occurs. This is significant because it is expected to provide information needed to better treat patients with newly diagnosed epilepsy and will contribute to future genetic therapeutic approaches.
Funding Period: 2009-04-01 - 2014-03-31
more information: NIH RePORT
- Valproate in children with newly diagnosed idiopathic generalized epilepsyK D Holland
Division of Neurology, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
Acta Neurol Scand 121:149-53. 2010..The aim of this study is to characterize the therapeutic dose of valproate in children with newly diagnosed IGE...
- Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcomeDennis Dlugos
Children s Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA
Neurology 81:150-6. 2013..In children with newly diagnosed childhood absence epilepsy (CAE), determine pretreatment EEG features and their associations with baseline neuropsychological function and short-term treatment outcome...
- mRNA blood expression patterns in new-onset idiopathic pediatric epilepsyHansel M Greiner
Division of Neurology, Department of Pediatrics, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229 3039, USA
Epilepsia 54:272-9. 2013..Determine the differential expression patterns between epilepsy patients with generalized onset or partial onset seizures compared to healthy controls...
- Selecting anti-epileptic drugs: a pediatric epileptologist's view, a computer's viewJ Pestian
Division of Biomedical Informatics, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
Acta Neurol Scand 127:208-15. 2013..To identify which clinical characteristics are important to include in clinical decision support systems developed for Antiepileptic Drug (AEDs) selection...
- Status epilepticus in childrenKatherine Holland
Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
Handb Clin Neurol 108:795-812. 2012....
- Resection of ictal high-frequency oscillations leads to favorable surgical outcome in pediatric epilepsyHisako Fujiwara
Division of Neurology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
Epilepsia 53:1607-17. 2012..However, HFOs can be difficult to detect because of their low amplitude. Therefore, the prevalence of ictal HFOs and their role in localization of epileptogenic zone on intracranial EEG are unknown...
- Nonconvulsive status epilepticus: the encephalopathic pediatric patientHansel M Greiner
Division of Child Neurology, Department of Pediatrics, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
Pediatrics 129:e748-55. 2012..This study examines prevalence of pediatric NCSE regardless of inpatient setting and retrospectively identifies risk factors indicating a need for urgent continuous EEG...
- Ictal MEG onset source localization compared to intracranial EEG and outcome: improved epilepsy presurgical evaluation in pediatricsHisako Fujiwara
Division of Neurology, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
Epilepsy Res 99:214-24. 2012..We investigated whether ictal MEG onset source localization further improves results of interictal MEG in defining the SOZ...
- Multimodality imaging in the surgical treatment of children with nonlesional epilepsyJ H Seo
Division of Pediatric Neurology, Department of Radiology, Cincinnati Children s Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH 45229 3339, USA
Neurology 76:41-8. 2011..To evaluate the diagnostic value of individual noninvasive presurgical modalities and to study their role in surgical management of nonlesional pediatric epilepsy patients...
- Gaps and opportunities in refractory status epilepticus research in children: a multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG)Iván Sánchez Fernández
Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children s Hospital, Harvard Medical School, Boston, MA, United States Department of Child Neurology, Hospital Sant Joan de Deu, University of Barcelona, Spain
Seizure 23:87-97. 2014....